2010 Annual Meeting | Genetics in Neurology

Date Friday 04/16/10

Time 09:00 AM - 05:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Full-Day Course

Director(s) Christine Klein, MD

Topic(s) Neurometabolic Disorders/Neurotoxicology/Neuroendocrinology, Cerebrovascular Disease and Interventional Neurology, Movement Disorders

Learning Objectives Participants should be able to incorporate new developments in the genetics and molecular mechanisms of inherited neurologic diseases.

CME Available No CME available

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement

Recommended Audience Other, Trainee, General Neurologist, Specialist Neurologist, Non-neurologist

Teaching Styles Case-based, Didactic

Event Timeline
09:00 AM - 09:40 AM		Introduction to Neurogenetics Using Parkinson Disease as an Example Christine Klein, MD
09:40 AM - 10:20 AM		Genetics of the Neuropathies Michael E. Shy, MD, FAAN
10:20 AM - 11:00 AM		Repeat Expansion Disorders Alexandra Durr, MD
11:00 AM - 11:30 AM		Break
11:30 AM - 12:10 PM		Genetics of Dementia Henry L. Paulson, MD, PhD, FAAN
12:10 PM - 12:50 PM		Neurogenetics Meets Environment Connie C. Marras, MD
12:50 PM - 01:50 PM		Lunch
01:50 PM - 02:30 PM		Role of Genetics in Common Neurodegenerative Diseases Lars Bertram
02:30 PM - 03:10 PM		Mitochondrial Diseases Carolyn M. Sue, MBBS, PhD, FRACP
03:10 PM - 03:40 PM		Break
03:40 PM - 04:20 PM		Translating Neurogenetics into Clinical Practice Dimitri Krainc, MD, PhD
04:20 PM - 05:00 PM		Inherited Dystonias and Genetic Testing Susan B. Bressman, MD, FAAN

Faculty Disclosures
Henry L. Paulson, MD, PhD, FAAN	Dr. Paulson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Exicure. The institution of Dr. Paulson has received research support from National Institutes of Health. Dr. Paulson has a non-compensated relationship as a Member, Nominating committee with American Neurological Association that is relevant to AAN interests or activities.
Christine Klein, MD	Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Centogene and Retromer Therapeutics. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Mov Disord, Ann Neurol, Science Adv. The institution of Dr. Klein has received research support from Centogene. Dr. Klein has received publishing royalties from a publication relating to health care.
Carolyn M. Sue, MBBS, PhD, FRACP	No disclosure on file
Connie C. Marras, MD	Dr. Marras has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine Biosciences. The institution of Dr. Marras has received research support from Theravance Inc. The institution of Dr. Marras has received research support from Centogene.
Alexandra Durr, MD	The institution of Dr. Durr has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. The institution of Dr. Durr has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Genetics. The institution of Dr. Durr has received research support from NIH. The institution of Dr. Durr has received research support from BIOGEN. The institution of Dr. Durr has received research support from MINORYX. The institution of Dr. Durr has received research support from TRIPLETS THERAPEUTICS. The institution of Dr. Durr has received research support from Servier. The institution of Dr. Durr has received research support from ANR. The institution of Dr. Durr has received research support from PTC.
Dimitri Krainc, MD, PhD	Dr. Krainc has nothing to disclose.
Susan B. Bressman, MD, FAAN	The institution of Dr. Bressman has received research support from Michael J Fox Foundation . The institution of Dr. Bressman has received research support from NIH .
Lars Bertram	No disclosure on file
Michael E. Shy, MD, FAAN	Dr. Shy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Applied Therapeutics. The institution of Dr. Shy has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for DTx Pharma. The institution of Dr. Shy has received research support from NIH. The institution of Dr. Shy has received research support from Muscular Dystrophy Association. The institution of Dr. Shy has received research support from Charcot Marie Tooth Association. The institution of Dr. Shy has received research support from Applied Therapeutics.